Moderna to acquire OriCiro Genomics
mRNA specialist Moderna will acquire OriCiro Genomics K.K, a pioneer in cell-free DNA synthesis and amplification technologies, for $85m.
Archives for January 5, 2023
Biogen and Alcyone Therapeutics partner up on novel device for neurological ASO therapies
Biogen and Alcyone Therapeutics have entered into a license and collaboration agreement to develop Alcyone’s ThecaFlex DRx System.
Delpharm acquires injectable drug development center in the Netherlands from Dr Reddy's
France headquartered CDMO, Delpharm, has expanded its pharmaceutical development services with the acquisition of the Leiden Development Centre from Dr Reddy's in the Netherlands.
FDA to review BLA for RSV antibody from AstraZeneca and Sanofi
AstraZeneca and Sanofi said their Biologics License Application (BLA) for nirsevimab has been accepted for review by the US Food and Drug Administration (FDA).